Cytokinetics (CYTK) Research & Development (2016 - 2025)
Historic Research & Development for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to $93.6 million.
- Cytokinetics' Research & Development rose 1018.29% to $93.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $339.4 million, marking a year-over-year increase of 281.26%. This contributed to the annual value of $339.4 million for FY2024, which is 281.26% up from last year.
- Latest data reveals that Cytokinetics reported Research & Development of $93.6 million as of Q4 2024, which was up 1018.29% from $84.6 million recorded in Q3 2024.
- Cytokinetics' 5-year Research & Development high stood at $93.6 million for Q4 2024, and its period low was $21.7 million during Q1 2020.
- Moreover, its 5-year median value for Research & Development was $59.9 million (2022), whereas its average is $58.4 million.
- As far as peak fluctuations go, Cytokinetics' Research & Development plummeted by 927.26% in 2020, and later skyrocketed by 10013.22% in 2021.
- Cytokinetics' Research & Development (Quarter) stood at $29.2 million in 2020, then surged by 48.86% to $43.5 million in 2021, then skyrocketed by 72.46% to $75.0 million in 2022, then increased by 13.27% to $85.0 million in 2023, then increased by 10.18% to $93.6 million in 2024.
- Its last three reported values are $93.6 million in Q4 2024, $84.6 million for Q3 2024, and $79.6 million during Q2 2024.